发明名称 |
CYSTEAMINE IN THE TREATMENT OF FIBROTIC DISEASE |
摘要 |
Fibrotic diseases are characterized by the replacement of healthy tissue with scar tissue and extracellular matrix in response to tissue damage. Here we describe the reduction of extracellular matrix (ECM) deposition, interstitial fibroblasts, interstitial volume, expression of Collagen I mRNA and protein, expression of profibrotic cytokines and macrophage infiltration by Cysteamine treatment. |
申请公布号 |
US2014275279(A1) |
申请公布日期 |
2014.09.18 |
申请号 |
US201114353273 |
申请日期 |
2011.10.26 |
申请人 |
Eddy Allison A.;Okamura Daryl M. |
发明人 |
Eddy Allison A.;Okamura Daryl M. |
分类号 |
A61K31/145;A61K45/06 |
主分类号 |
A61K31/145 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating a fibrotic disease comprising administering, to a patient in need thereof, an effective amount of cysteamine, or a salt thereof; wherein the administration of cysteamine, or a salt thereof, results in amelioration of a fibrotic disease in the patient. |
地址 |
Seattle WA US |